Medications with Generic Name Beginning ‘D’

Page 1 of 428 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

Pradaxa (Dabigatran Etexilate)

PRADAXA Oral Pellets are a direct thrombin inhibitor indicated: For the treatment of venous thromboembolic events (VTE) in pediatric patients aged 3 months to less than 12 years of age…

Boehringer Ingelheim Pharmaceuticals, Inc.1 April 2022

Dabigatran Etexilate

Dabigatran Etexilate Capsules is a direct thrombin inhibitor indicated: To reduce the risk of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (1.1)…

Ascend Laboratories, LLC23 June 2022

Dabigatran Etexilate

Dabigatran etexilate capsules are a direct thrombin inhibitors indicated: To reduce the risk of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (1.1)…

American Health Packaging30 March 2023

Dabigatran Etexilate

Dabigatran etexilate capsules are a direct thrombin inhibitors indicated: To reduce the risk of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (1…

Camber Pharmaceuticals, Inc.8 July 2023

PRADAXA (Dabigatran Etexilate Mesylate)

PRADAXA is indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. PRADAXA is a direct thrombin inhibitor indicated to reduce the risk of stroke and systemic embolism in patients with…

Rebel Distributors Corp23 November 2010

Page 1 of 428 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

FDA Medwatch

KVK-Tech, Inc. Issues Voluntary Nationwide Recall of One Lot of Betaxolol Tablets, USP 10 mg (Batch Number: 17853A) as a Precautionary Measure Due to a Single Foreign Tablet Found During the Line Clearance After the Batch was Packaged
Mon, 02 Oct 2023. Newtown, Pennsylvania, KVK-Tech, Inc. is voluntarily recalling one lot (Batch Number: 17853A; “the batch”) of Betaxolol Tablets, USP 10 mg, White, Round, film coated biconvex tablets, debossed “K” above bisect “13” on one side and plain…
Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination
Sun, 01 Oct 2023. Charlottesville, VA – Biomic Sciences is voluntarily recalling all lots of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray products to the consumer level. FDA testing found the product to contain microbial contamination identified as…

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.